rs76202659

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000384.3(APOB):​c.1353-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00267 in 1,551,580 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.013 ( 40 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 40 hom. )

Consequence

APOB
NM_000384.3 intron

Scores

2
Splicing: ADA: 0.00008316
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: -0.0720

Publications

3 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 2-21030027-G-A is Benign according to our data. Variant chr2-21030027-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 265880.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0131 (1997/152312) while in subpopulation AFR AF = 0.0456 (1895/41556). AF 95% confidence interval is 0.0439. There are 40 homozygotes in GnomAd4. There are 946 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 40 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.1353-12C>T
intron
N/ANP_000375.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.1353-12C>T
intron
N/AENSP00000233242.1
APOB
ENST00000399256.4
TSL:1
c.1353-12C>T
intron
N/AENSP00000382200.4
APOB
ENST00000673739.2
n.*659-12C>T
intron
N/AENSP00000501110.2

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1990
AN:
152194
Hom.:
40
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0456
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00372
AC:
934
AN:
251290
AF XY:
0.00265
show subpopulations
Gnomad AFR exome
AF:
0.0481
Gnomad AMR exome
AF:
0.00240
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000220
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00154
AC:
2152
AN:
1399268
Hom.:
40
Cov.:
24
AF XY:
0.00141
AC XY:
984
AN XY:
700330
show subpopulations
African (AFR)
AF:
0.0496
AC:
1592
AN:
32112
American (AMR)
AF:
0.00262
AC:
117
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.00190
AC:
49
AN:
25726
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39394
South Asian (SAS)
AF:
0.000435
AC:
37
AN:
85006
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53342
Middle Eastern (MID)
AF:
0.00389
AC:
22
AN:
5654
European-Non Finnish (NFE)
AF:
0.000100
AC:
106
AN:
1054980
Other (OTH)
AF:
0.00390
AC:
228
AN:
58418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
99
199
298
398
497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1997
AN:
152312
Hom.:
40
Cov.:
33
AF XY:
0.0127
AC XY:
946
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0456
AC:
1895
AN:
41556
American (AMR)
AF:
0.00314
AC:
48
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68026
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00945
Hom.:
17
Bravo
AF:
0.0148
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Hypercholesterolemia, familial, 1 (2)
-
-
2
not provided (2)
-
-
1
Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
11
DANN
Benign
0.68
PhyloP100
-0.072
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000083
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76202659; hg19: chr2-21252899; API